je.st
news
Home
›
Genedata Announces Collaboration with AstraZeneca on the Analysis of Compound Combination ...
Genedata Announces Collaboration with AstraZeneca on the Analysis of Compound Combination ...
2013-12-03 06:00:00| Industrial Newsroom - All News for Today
Genedata Screener® serves as the data analysis platform for high-throughput compound combination experiments in oncology and infectious diseases <br /> <br /> Basel, Switzerland – Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced its successful collaboration with AstraZeneca on data analysis for compound combination experiments. Drug combination studies, which are increasingly used in pre-clinical research, produce ...This story is related to the following:Scientific Software | Data Analysis Software
Tags: analysis
combination
collaboration
compound
Category:Industrial Goods and Services